Human kallikrein 6 as a biomarker of Alzheimer's disease

Clinical Biochemistry

Volumn 33, Issue 8, 2000, Pages 663-667

  Diamandis, Eleftherios P ^a,b   Yousef, George M ^a,b   Petraki, Constantina ^c   Soosaipillai, Antoninus R ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Alzheimer's disease; Brain; Cerebrospinal fluids; Diagnostic tests; Human kallikrein 6; Human kallikreins

Indexed keywords

AMYLOID BETA PROTEIN; BIOCHEMICAL MARKER; KALLIKREIN; KALLIKREIN 6; TISSUE EXTRACT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BLOOD ANALYSIS; CEREBROSPINAL FLUID; CHOROID PLEXUS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034483227     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(00)00185-5     Document Type: Article

References (35)

1. Translating cell biology into therapeutic advances in Alzheimer's disease
2. The pathogenesis of senile plaques
3. Amyloid plaque core protein in Alzheimer's disease and Down Syndrome
4. Tau protein and the neurofibrillary pathology of Alzheimer's disease
5. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRA Work Group under the autopsies of department of health and human services task force on Alzheimer's disease
6. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: A clinicopathologic study of 57 cases
7. Diagnostic accuracy of Alzheimer's disease: A clinicopathological study
8. Clinical-neuropathological correlations in Alzheimer's disease and related dementias
9. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: A community based follow up study
10. Cerebrospinal fluid levels of Aβ42 and tau: Potential markers of Alzheimer's disease
11. Tau protein in cerebrospinal fluid: A biochemical diagnostic marker for axonal degeneration in Alzheimer's disease?
12. Tau protein concentration in cerebrospinal fluid of patients with dementia of the Alzheimer's type
13. Tau in cerebrospinal fluids: Establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau
14. Tau protein in cerebrospinal fluid: A new diagnostic and prognostic marker in Alzheimer disease?
15. (1-42) and tau levels in CSF
16. Tau protein concentrations in cerebrospinal fluid of non-demented Parkinson's disease patients
17. Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans. HIV Neurobehavioral Research Center Group
18. Increased CSF tau protein in corticobasal degeneration
19. A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy
20. Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease
21. Sensitivity, specificity and stability of CSF-tau in AD in a community-based patient sample
22. Reduction of β-amyloid peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease
23. High cerebrospinal fluid tau and low amyloid β-42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype
24. Longitudi na 1 study of cerebrospinal fluid levels of tau, a β1-40 and A β1-42 (43) in Alzheimer's disease: A study in Japan
25. CSF-tau and CSF-Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment
26. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease
27. Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid
28. Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker
29. Specificity of AD7C-NTP as a biochemical marker for Alzheimer's disease
30. Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain
31. A novel protease homolog differentially expressed in breast and ovarian cancer
32. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain
33. Molecular characterization of zyme-protease M/neurosin, a hormonally-regulated kallikrein-like serine protease
34. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications
35. Quantification of p53 protein in tumor cell lines, breast tissue extracts and serum with time-resolved immunofluorometry